ACTIVE SUBSTANCE / INN

RUXOLITINIB PHOSPHATE

Brand name(s): OPZELURA, JAKAFI
FDA LISTED
PRESCRIPTION
NDA202192
NDA215309
ACTIVE SUBSTANCE
Ruxolitinib Phosphate
REGULATORS
FDA
SPONSORS / MAH
INCYTE CORP
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
OPZELURANDA215309INCYTE CORPPrescription
JAKAFINDA202192INCYTE CORPPrescription

FULL INTELLIGENCE ON RUXOLITINIB PHOSPHATE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →